Schedule 13G ownership disclosure

Amicus Therapeutics Inc

Common Stock, par value $0.01 per share · CUSIP: 03152W109

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Avoro Capital Advisors LLC

    Shares: 15,025,000.00 · Class: 4.87%

  • Behzad Aghazadeh

    Shares: 15,025,000.00 · Class: 4.87%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-004945
Form type
SCHEDULE 13G/A
Filer
AMICUS THERAPEUTICS, INC.
CIK
CIK 1178879
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub